In 2018, Florida implemented a law limiting opioid prescriptions to a three-day supply for patients without chronic pain.
To assess the outcomes of this law, researchers analyzed claims data for 54,409 opioid prescriptions dispensed between January 2015 and March 2019 from one private health plan covering more than 45,000 employees in Florida.
Before the law was enacted, there were 5.5 new opioid users per 1,000 enrollees. This figure fell to 4.6 new opioid users per 1,000 enrollees after the law took effect. The average length of opioid prescriptions also fell from 5.4 days to 4.2 days per prescription over the study period.
Researchers noted the findings may not be generalizable since the study only focuses on patients from one health plan.
To view the full study, click here.
More articles on opioids:
Ohio county considers adding 2nd morgue for surge in opioid overdose deaths
Medicaid expansion linked to drop in opioid overdose deaths
How Houston Methodist reduced opioid prescriptions by nearly 77%
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
